Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches
Shoichi Takikita(National Institutes of Health), Paul H. Plötz(National Institutes of Health), Kristien J.M. Zaal(National Institutes of Health), Nina Raben(APT Therapeutics (United States)), Rachel Myerowitz(National Institutes of Health)
Cited by 39
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395